Press Releases 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Eagle Pharmaceuticals’ Presentation at Piper Sandler 32nd Annual Virtual Healthcare Conference Available for Viewing 11/23/20 Eagle Pharmaceuticals Reports Third Quarter 2020 Results 11/2/20 Eagle Pharmaceuticals Strengthens Management Team to Prepare for Future Growth 11/2/20 Eagle Pharmaceuticals to Discuss Third Quarter 2020 Financial Results on November 2, 2020 10/26/20 Eagle Pharmaceuticals Commences $25 Million Accelerated Share Repurchase as Part of Existing $160 Million Share Repurchase Program 9/24/20 Eagle Pharmaceuticals’ Japanese Licensing Partner, SymBio, Receives Approval of TREAKISYM Ready-To-Dilute (“RTD”) Formulation, with Launch Expected in January 2021 9/23/20 Eagle Pharmaceuticals to Present at Upcoming September 2020 Healthcare Conferences 9/8/20 Eagle Pharmaceuticals Announces Publication of Preclinical Study of Intranasal Dantrolene in Journal of Alzheimer’s Disease 8/19/20 Eagle Pharmaceuticals Reports Second Quarter 2020 Results 8/10/20 Eagle Pharmaceuticals to Discuss Second Quarter 2020 Financial Results on August 10, 2020 8/3/20 Pagination Current page 1 Page 2 Page 3 Next page Last page
